← Back to Search

Brachytherapy

Hydrogel Packing System for Cervical Cancer

N/A
Waitlist Available
Led By Kara Romano
Research Sponsored by University of Virginia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
FIGO IB1 - IVB Staging according to FIGO and TNM guidelines
Karnofsky performance status (KPS) ≥ 70 or ECOG status ≤1
Must not have
Plan to receive external beam RT (EBRT) alone as the definitive treatment plan for the cancer of interest
Known contraindications to brachytherapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up fractions/radiation treatments 2 - 5: about 1-4 weeks after starting brachytherapy
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new, low cost packing system for brachytherapy to see if it is as effective as the standard options, and to understand any associated discomfort and safety concerns.

Who is the study for?
This trial is for adults over 18 with cervical cancer who are planning to receive brachytherapy. They must have a performance status indicating they can carry out daily activities and agree to lifestyle considerations during the study. Those with prior pelvic radiation, hysterectomy, or pregnant/lactating individuals cannot participate.
What is being tested?
The study compares a new low-cost packing system called 'BrachyGel VHPS' against standard options used in high-dose-rate (HDR) brachytherapy for cervical cancer. It aims to ensure BrachyGel VHPS protects nearby organs from radiation effectively and assesses patient safety and comfort.
What are the potential side effects?
While specific side effects of BrachyGel VHPS aren't detailed, potential risks may include discomfort at the application site, possible allergic reactions to materials in the hydrogel, and typical brachytherapy-related side effects like localized pain or bleeding.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My cervical cancer is between stages IB1 and IVB.
Select...
I am mostly able to care for myself and carry out daily activities.
Select...
I am planning to undergo brachytherapy for my cervical cancer treatment.
Select...
My biopsy shows I have cervical cancer.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am scheduled for external beam radiation therapy as my main cancer treatment.
Select...
I cannot have brachytherapy due to health reasons.
Select...
I have had a hysterectomy.
Select...
I have had radiation therapy in my pelvis or abdomen not related to my current cancer treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~fractions/radiation treatments 2 - 5: about 1-4 weeks after starting brachytherapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and fractions/radiation treatments 2 - 5: about 1-4 weeks after starting brachytherapy for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Highest dose of radiation (in Gy) to the rectum and bladder for each patient
Secondary study objectives
Adverse Events
Highest dose of radiation (in Gy) to the rectum and bladder for each patient at each treatment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm B: BrachyGel in fractions 2 and 4Experimental Treatment1 Intervention
BrachyGel VHPS in fractions 2 and 4 and standard packing in fractions 3 and 5
Group II: Arm A: BrachyGel in fractions 3 and 5Experimental Treatment1 Intervention
BrachyGel VHPS in fractions 3 and 5 and standard packing in fractions 2 and 4

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor
782 Previous Clinical Trials
1,315,704 Total Patients Enrolled
BrachyFoam, LLCUNKNOWN
Kara RomanoPrincipal Investigator - University of Virginia
University of Virginia

Media Library

BrachyGel VHPS (Brachytherapy) Clinical Trial Eligibility Overview. Trial Name: NCT04499521 — N/A
Cervical Cancer Research Study Groups: Arm B: BrachyGel in fractions 2 and 4, Arm A: BrachyGel in fractions 3 and 5
Cervical Cancer Clinical Trial 2023: BrachyGel VHPS Highlights & Side Effects. Trial Name: NCT04499521 — N/A
BrachyGel VHPS (Brachytherapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04499521 — N/A
~4 spots leftby Nov 2025